Georgia Tech is finalizing a deal to purchase approximately 5 acres of land from Coca-Cola, located near the beverage giant's headquarters along North Avenue. The transaction, valued at over $30 million, aims to expand the research university's campus and create a major innovation and entertainment district. This move is expected to support Georgia Tech's strategic growth, research needs, and rising enrollment.

Mutual funds invested ₹17,250 crore into HDFC Bank in March 2026, despite a significant 17% fall in its share price. This influx of domestic institutional investment, led by ICICI Prudential, SBI, and Nippon India Mutual Funds, helped offset a sharp decline in foreign institutional holdings following a corporate governance scare. The Reserve Bank of India clarified there were no material concerns regarding the bank's operations, leading to mutual funds accumulating the stock at lower valuations.

Assetmark Inc. reduced its stake in Cadence Design Systems (NASDAQ:CDNS) by 4.2% in Q4 2025, selling 4,732 shares and retaining 108,702 shares valued at $33.98 million. Despite this sale, Cadence Design Systems exceeded analyst expectations for Q4 earnings and revenue, with analysts maintaining a "Moderate Buy" consensus rating and an average target price of $376.50. The company also provided strong guidance for Q1 and full-year 2026.

Assetmark Inc. increased its stake in Tyler Technologies (NYSE:TYL) by 7.8% during the fourth quarter, now owning 68,802 shares valued at approximately $31.23 million. Other institutional investors also adjusted their positions, with hedge funds and institutional investors collectively owning roughly 93.30% of the company's stock. Despite the increased institutional interest, Tyler Technologies missed fourth-quarter EPS and revenue estimates, though its revenue was up 6.3% year-over-year.

Ascent Group LLC has increased its stake in Alphabet Inc. (NASDAQ:GOOGL) by 3.2% in the fourth quarter, making it their 10th largest holding. Several other institutional investors also adjusted their positions in Alphabet, which now has a market capitalization of $4.03 trillion. The company recently announced a quarterly dividend and received mostly "buy" ratings from analysts, with a consensus target price of $367.06.

Assetmark Inc. increased its stake in Agilent Technologies, Inc. by 5.9% in Q4, acquiring an additional 12,984 shares. Other institutional investors also adjusted their holdings, with Massachusetts Financial Services Co. significantly increasing its stake by 13.8%. Agilent Technologies slightly missed Q4 revenue and EPS estimates but provided positive FY2026 EPS guidance and declared a quarterly dividend.

RELX plc, a data and analytics powerhouse, stands out due to its business model leveraging irreplaceable data assets and analytics platforms across legal, scientific, and exhibitions sectors. In a data-driven world, its entrenched position in providing essential services through proprietary data and AI-driven insights makes it a resilient growth play for investors, particularly in the United States and English-speaking markets. The company's focus on high-margin, subscription-based services, coupled with strong cash flow and strategic acquisitions, positions it well for continued growth amidst economic shifts and increasing data needs.

Waters Corp (WAT) is a leading provider of high-performance liquid chromatography and mass spectrometry tools, critical for pharmaceuticals, biotech, and materials science. The company's focus on innovation, diversified end-markets, and strong financial stability positions it as an evergreen investment in the life sciences sector. Its emphasis on digital solutions, sustainability, and recurring revenue from consumables further solidifies its market relevance for investors seeking defensive growth.

BCS Wealth Management significantly increased its stake in Merck & Co., Inc. by 103.0% in the fourth quarter, now holding 31,956 shares valued at $3.36 million. This comes amidst varied institutional investor activity, positive analyst sentiment, and FDA priority review for a new cancer drug, while the company also faces reputational and policy risks concerning drug pricing. Merck's stock currently holds a "Moderate Buy" consensus rating with a target price of $128.47.

PACCAR Inc. is a dominant force in the heavy-duty truck sector, manufacturing brands like Kenworth and Peterbilt, and is positioned for resilient growth due to its vertically integrated model, focus on engineering excellence, and strong aftermarket parts business. The company's strategy includes significant R&D investment, a global footprint with North America as its core, and a focus on shareholder returns and new technologies like electrification. While cyclical demand and supply chain issues pose risks, PACCAR's competitive advantages and alignment with freight and infrastructure trends make it an appealing investment for stability in industrial sectors.